Association of DRB1 and DQB1 HLA class II polymorphisms in high-grade and neoplastic cervical lesions of women from Argentina

Journal of Lower Genital Tract Disease

Volumn 12, Issue 4, 2008, Pages 262-268

  Eiguchi, Kumiko ^a   Tatti, Silvio ^b   Alonio, L Virginia ^c   González, Joaquín V ^c   Leirós, Gustavo J ^a   Fleider, Laura ^b   Vighi, Susana ^b   Padros, Karin ^d   Raimondi, Eduardo ^d   Teyssié, Angélica ^c   Picconi, M Alejandra ^c  

^a UNIVERSIDAD DEL SALVADOR   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

Author keywords

Cervical cancer; Cervical lesions; HLA DQB1; HLA DRB1; Human papillomavirus

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARGENTINA; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOT HYBRIDIZATION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HLA TYPING; HUMAN; HUMAN TISSUE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; ALLELES; ARGENTINA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 55149109658     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181729285     Document Type: Article

References (39)

1. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
2. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.
3. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
5. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88:63-73.
6. Londesborough P, Ho L, Terry G, Cuzick J, Wheeler C, Singer A. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int J Cancer 1996;69:364-8.
7. Remmink AJ, Walboomers JM, Heimerhorst TJ, Voorhorst FJ, Rozendaal L, Risse EK, et al. The presence of persistent high risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 1995;61:306-11.
8. Zur Hausen H. Papillomavirus causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-98.
9. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002;89:229-40.
10. Stern PL. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination. J Clin Virol 2005;32(Suppl 1):S72-81.
11. Wank R, Schendel DJ, Thomssen C. HLA antigens and cervical carcinoma. Nature 1992;356:22-3.
12. Helland A, Borresen AL, Kaern J, Ronningen KS, Thorsby E. HLA antigens and cervical carcinoma. Nature 1992;356:23.
13. Gregoire L, Lawrence WD, Kukuraga D, Eisenbrey AB, Lancaster WD. Association between HLA-DQB1 alleles and risk for cervical cancer in African-American women. Int J Cancer 1994;57:504-7.
14. Apple RJ, Erlich H, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6:157-62.
15. Dao DD, Sierra-Torres CH, Robazetti SC, de Gomez MN, König R, Lema C, et al. HLA-DQB1 and cervical cancer in Venezuelan women. Gynecol Oncol 2005;96:349-54.
16. Silva B, Vargas-Alarcon G, Zuniga-Ramos J, Rodriguez-Reyna TS, Hernandez-Martinez B, Osanaya N, et al. Genetic features of Mexican women predisposing to cancer of the uterine cervix. Hum Pathol 1999;30:626-8.
17. Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML. Major histocompatibility complex II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000;9:1183-91.
18. Sastre-Garau X, Loste MN, Vincent-Salomon A, Favre M, Mouret E, de la Rochefordiere A, et al. Decreased frequency of HLA-DRB1 13 alleles in French women with HPV-positive carcinoma of the cervix, Int J Cancer 1996;69:159-64.
19. Lin P, Koutsky LA, Critchlow CW, Apple RJ, Hawes SE, Hughes JP, et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 2001;10:1037-45.
20. Madeleine MM, Brumback B, Cushing-Haugen KL, Schwartz SM, Daling JR, Smith AG, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 2002;186:1565-74.
21. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQwS. Nature 1991;352:723-5.
22. Nawa A, Nishiyama Y, Kobayashi T, Wakahara Y, Okamoto T, Kikkawa F, et al. Association of HLA-B1 *03 with cervical cancer in Japanese women aged 35 years and younger. Cancer 1995;75:518-21.
23. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, Delius H, et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001;94:711-6.
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
25. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature 1986;324:163-6.
26. Bernard HU, Chan S-Y, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogentic algorithms. J Inf Dis 1994;170:1077-85.
27. de Roda Husman AM, Walboomers JMM, van den Brule AJC, Meijer CJL, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
28. Picconi MA, Gronda J, Alonio LV, Villa LL, Sichere L, Miranda S, et al. Human papillomavirus (HPV) in Quechua women from Jujuy, with high frequency of cancer of the cervix: viral types and HPV-16 variants. Medicina (B Aires) 2002;62: 209-20.
29. Cuzick J, Terry G, Ho L, Monaghan J, Lopes A, Clarkson P, et al. Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br J Cancer 2000;82:1348-52.
30. Yang YC, Chang TY, Lee YJ, Su TH, Dang CW, Wu CC, et al. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis. Hum Immunol 2006;67:331-40.
31. Lema C, Fuessel-Haws AL, Lewis LR, Rady PL, Lee P, Turbat-Herrera, et al. Association between HLA-DQB1 and cervical dysplasia in Vietnamese women. Int J Gynecol Cancer 2006;16:1269-77.
32. Beskow AH, Josefsson AM, Gyllenstein UB. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 2001;93:817-22.
33. Wang SS, Wheeler CM, Hildesheim A, Schiffman M, Herrero R, Bratti MC, et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001;184:1310-4.
34. Sastre-Garau X, Cartier I, Jourdan-Da Silva N, De Cremoux P, Lepage V, Charron D. Regression of low grade cervical intraepithelial neoplasia in patients with HLA-DRB1*13. Obstet Gynecol 2004;104:751-5.
35. Wang SS, Wheeler CM, Hildesheim A, Schiffman M, Herrero R, Bratti MC, et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001;184:1310-4.
36. Chan PK, Cheung TH, Lin CK, Siu SS, Yim SF, Lo KW, et al. Association between HLA-DRB1 polymorphism, highrisk HPV infection and cervical neoplasia in southern Chinese. J Med Virol 2007;79:970-6.
37. Montoya L, Saiz I, Rey G, Vela F, Clerici-Larradet N. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur J Immunogenet 1998;5:329-37.
38. Neuman RJ, Huettner PC, Li L, Mardis ER, Duffy BF, Wilson RK, et al. Association between DQB1 and cervical cancer in patients with human papillomavirus and family controls. Obstet Gynecol 2000;95:134-40.
39. Peng S, Trimble C, Wu L, Pardoll D, Roden R, Hung CF, et al. HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions. Clin Cancer Res 2007;13:2479-87.